Chandiramohan Abiram J, Zahabi Sarah, Sowerby Leigh, You Peng, Davidson Jacob, Dann Celia, Strychowsky Julie E
Faculty of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.
Department of Otolaryngology-Head and Neck Surgery, Western University, London, ON, Canada.
J Otolaryngol Head Neck Surg. 2025 Jan-Dec;54:19160216251328883. doi: 10.1177/19160216251328883. Epub 2025 Mar 26.
ImportanceePrescriptions are associated with increased patient satisfaction, decreased provider burden, decreased administrative costs, and a positive impact on planetary health. However, ePrescription uptake by physicians is historically low and acts as a barrier to reaping the benefits therein.ObjectiveWe aimed to attain 20% overall usage of ePrescriptions in the Department of Otolaryngology-Head and Neck Surgery (OHNS) at the London Health Sciences Centre (LHSC) by December 2023 through systematic implementation of change ideas.DesignPre-post intervention design.SettingAmbulatory clinics in OHNS at LHSC, an academic hospital.ParticipantsFourteen staff and 15 resident physicians in OHNS; 38 patients in pediatric otolaryngology clinic.Intervention or ExposureA root-cause analysis identified potential obstacles to ePrescribing. Change ideas, including educational seminars, surveys, quarterly reporting of ePrescription usage, and public encouragement of top ePrescribers in the department, were implemented and tested using Plan-Do-Study-Act cycles.Main Outcome MeasuresPercent ePrescription usage and carbon footprint savings associated with ePrescriptions were measured. Provider and patient satisfaction surveys were conducted as balancing measures to assess for the perception of increased burden on providers.ResultsDuring the pre-intervention and post-intervention phases, a total of 400 and 1000 ePrescriptions were prescribed by the department, respectively. There was a statistically-significant increase in the mean proportion of ePrescriptions used before (mean: 9.7%; sd = 7.6) and after (mean: 40.7%; sd = 6.4) the intervention ( < 0.001), which exceeded the goal. SPC charting suggested special cause variation, signifying a statistically-significant improvement. Additionally, a reduction of 125.9 lbs of CO equivalents was associated with ePrescription use. 66.7% of providers rated overall satisfaction with ePrescriptions at 7/10 or higher, and 76.9% indicated that patients either sometimes, usually, or always opted for ePrescriptions when given the choice.Conclusion and RelevantOur change ideas increased ePrescription usage in an academic OHNS department and were associated with increased planetary health savings and provider satisfaction.
重要性
电子处方与提高患者满意度、减轻医疗服务提供者负担、降低行政成本以及对地球健康产生积极影响相关。然而,从历史上看,医生对电子处方的采用率很低,这成为了获取其中益处的障碍。
目的
我们旨在通过系统实施变革理念,到2023年12月在伦敦健康科学中心(LHSC)的耳鼻咽喉头颈外科(OHNS)实现电子处方总体使用率达到20%。
设计
干预前后设计。
背景
LHSC的一家学术医院中OHNS的门诊诊所。
参与者
OHNS的14名工作人员和15名住院医师;儿科耳鼻咽喉科诊所的38名患者。
干预或暴露
根本原因分析确定了电子处方开具的潜在障碍。通过计划 - 执行 - 研究 - 行动循环实施并测试了变革理念,包括教育研讨会、调查、电子处方使用情况的季度报告以及在科室公开鼓励顶级电子处方开具者。
主要结局指标
测量电子处方使用百分比以及与电子处方相关的碳足迹节省情况。进行医疗服务提供者和患者满意度调查作为平衡措施,以评估对医疗服务提供者负担增加的看法。
结果
在干预前和干预后阶段,该科室分别开具了400份和1000份电子处方。干预前(均值:9.7%;标准差 = 7.6)和干预后(均值:40.7%;标准差 = 6.4)使用电子处方的平均比例有统计学显著增加(< 0.001),超过了目标。统计过程控制图显示有特殊原因变异,表明有统计学显著改善。此外,电子处方使用减少了125.9磅二氧化碳当量。66.7%的医疗服务提供者对电子处方的总体满意度评分为7/10或更高,76.9%表示患者在有选择时有时、通常或总是选择电子处方。
结论及相关性
我们的变革理念提高了学术性OHNS科室的电子处方使用率,并与地球健康节省增加和医疗服务提供者满意度提高相关。